HCC: Management of Adverse Events with New Therapeutic Approaches

Earn CME:

In this webcast from the 'Making Progress in Advanced Hepatocellular Carcinoma with Targeted Agents: Considerations for Therapeutic Selection, Toxicity Management, and Sequencing' symposium during the 2019 Great Debates & Updates in Gastrointestinal Malignancies conference, Dr. Pashtoon Kasi discusses best practices for the management of adverse events associated with the treatment of HCC.

© 2019 Imedex, an HMP Company

Imedex,CME,Continuing Medical Education,Education,Accreditation,Medical,Nurse,Residents-in-Training,Fellows,Physician,Clinician,Physician-in-training,HMP CME,gi cancer,gi malignancy,gi malignancies,gastrointestinal cancer,gastrointestinal malignancies,